Transplantační medicína

Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.¹ The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.² Assays for detecting autoimmune T1D have shown high sensitivity and specificity.^3,4

Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.¹ The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.² Assays for detecting autoimmune T1D have shown high sensitivity and specificity.^3,4

Efficacy of Nirsevimab Over 6 Months: A 180-Day Endpoint Analysis from the HARMONIE Study, a Randomized Phase IIIb trial
Alasdair P.S. Munro, PhD1, 2., Simon B. Drysdale, PhD., FRCPCH3, 4., Katrina Cathie, MD., FRCPCH1, 2., Florence Flamein, MD., PhD5, 6., Markus Knuf, PhD7, 8., Andrea M. Collins, MD., PhD9,10., Helen C. Hill, PhD9., Friedrich Kaiser, MD11., Robert Cohen, MD12., Didier Pinquier, MD13., Natalya C. Vassilouthis, MD14., Mariana Carreno, MD15., Catherine Moreau, MSc16., Pierre Bourron, PharmD17., Lydie Marcelon, PhD18., Karine Mari, PhD19., Michelle Roberts, MD20., Pierre Tissières, MD., DSc21,22., Simon Royal, MPH., MRCGP23., and Saul N. Faust, PhD., FRCPCH1, 2., for the HARMONIE Study Group. doi:10.2139/ssrn.4995419..